Related Experiment Video

Updated: May 10, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Beyond amyloid positivity: Biological heterogeneity in the real-world use of lecanemab

Michael S Rafii1

  • 1Epstein Family Alzheimer's Therapeutic Research Institute, Keck School of Medicine of University of Southern California, the United States of America.

The Journal of Prevention of Alzheimer'S Disease
|May 8, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ARIAAlzheimer's diseaseAmyloidAnti-amyloidReal-world evidence

More Related Videos

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
10:04

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections
07:28

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Published on: May 19, 2022

Related Experiment Videos

Last Updated: May 10, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
10:04

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections
07:28

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Published on: May 19, 2022

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...

Articles linked to this work by shared authors, journal, and citation graph.

Blood pressure and transcranial ultrasound predict moyamoya vasculopathy in Down syndrome.

Developmental medicine and child neurology·2026

Sex-specific biological aging clocks across organs and omics.

Nature medicine·2026

Delayed Recognition and Stroke-Predominant Presentation in Down Syndrome-Associated Moyamoya Syndrome.

Stroke·2026

Relationships between longitudinal retinal amyloid imaging and amyloid PET in the A4 Trial.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

Facial feature removal in magnetic resonance imaging scans of adults with Down syndrome: A de-facing methodological study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Immunosuppression in down syndrome regression disorder: a prospective observational cohort study.

Brain communications·2026

Pharmacological interventions for reducing the risk of cognitive decline and dementia after stroke/transient ischemic attack: A systematic review.

The journal of prevention of Alzheimer's disease·2026

Feasibility of immersive 40 Hz gamma sensory stimulation in early-stage Alzheimer's disease.

The journal of prevention of Alzheimer's disease·2026

Evoke (+) trials of semaglutide for early alzheimer's disease: Innovations, lessons, and implications.

The journal of prevention of Alzheimer's disease·2026

Autopsy findings in Alzheimer's disease clinical trial participants demonstrate a high frequency of off-target coexisting pathologic features.

The journal of prevention of Alzheimer's disease·2026

Characterization of a metabolomics signature of the brain-health-promoting MIND diet in older persons.

The journal of prevention of Alzheimer's disease·2026

Prevalence, risk factors, and racial disparities in probable and possible dementia: the national health and aging trends study.

The journal of prevention of Alzheimer's disease·2026

Case Report: Efgartigimod in refractory non-tumor Lambert-Eaton myasthenic syndrome.

Frontiers in immunology·2026

Thymic CT attenuation score in SAPHO syndrome: a comparative study with rheumatoid arthritis, ankylosing spondylitis, and healthy controls.

Frontiers in immunology·2026

Circulating angiogenic T cells as potential immune-vascular biomarkers associated with disease activity in axial spondyloarthritis.

Frontiers in immunology·2026

Immune profiling of anti-SSA-positive at-risk individuals reveals increased type I IFN activity preceding lymphocyte abnormalities in Sjögren's disease.

Frontiers in immunology·2026

Case Report: IgG4-related lung disease.

Frontiers in immunology·2026

Anti-GBM disease shortly after clinically presumed ANCA-associated vasculitis in an 85-year-old patient: a case report and literature review.

Frontiers in nephrology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us